Stroke Reports
Friday, October 4th, 2013
Annals: October 2013 Background: Dual-antiplatelet regimens for prevention of recurrent stroke promote antithrombotic effects but may increase the risk for hemorrhage. Purpose: To qualitatively and quantitatively examine the risk for recurrent stroke and intracranial hemorrhage (ICH) linked to long-term dual- and single-antiplatelet therapy among patients with ischemic stroke and transient ischemic attack. Data Sources: PubMed, EMBASE, and the Cochrane Central […]
Stroke Reports
Friday, October 4th, 2013
STROKEAHA: October 1, 2013 Background and Purpose—The purpose of the present study was to investigate the 4-year mortality risk among patients <55 years with a first ischemic stroke during 1987–2006. Methods—A total of 17 149 cases (37.4% women) aged 18 to 54 years who survived ≥28 days after a first ischemic stroke were identified in the […]
Stroke Reports
Friday, October 4th, 2013
Neurosurgery: October 2013 BACKGROUND: Stroke is a leading cause of death and disability in the United States. Despite the proven benefits of intravenous tissue plasminogen activator (IV-tPA), only a small percentage of patients who have had a stroke (3.4%–5.2%) receive this US Food and Drug Administration-approved therapy. OBJECTIVE: To prospectively assess the impact of a telestroke […]
Stroke Reports
Friday, October 4th, 2013
he Lancet Neurology: October 2013 A fifth of all strokes and transient ischaemic attacks occur in the posterior circulation arterial territory. Diagnosis can be challenging, in part because of substantial overlap in symptoms and signs with ischaemia in the anterior circulation. Improved methods of non-invasive imaging of the vertebrobasilar arterial tree have been used in recent […]
